Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Renal Cell × Metformin × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 11 Polycystic Ovary Syndrome 9 Colorectal Neoplasms 9 Lung Neoplasms 8 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Neoplasms 5 Glioblastoma 5 Lymphoma, Large B-Cell, Diffuse 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Rectal Neoplasms 3 Melanoma 3 Leukoplakia, Oral 3 Insulin Resistance 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Diabetes Mellitus 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2

Interventions

Sunitinib 52 Nivolumab 45 Sorafenib 35 Bevacizumab 31 Axitinib 31 pembrolizumab 29 cabozantinib 28 Everolimus 25 pazopanib 23 aldesleukin 23 Ipilimumab 21 Interleukin-2 17 Magnetic Resonance Spectroscopy 15 Interferon-alpha 15 Gemcitabine 15 lenvatinib 13 Specimen Handling 13 Radiosurgery 12 Interferon alpha-2 12 Cyclophosphamide 12 fludarabine phosphate 11 Erlotinib Hydrochloride 8 temsirolimus 7 atezolizumab 7 Introns 7 Capecitabine 7 durvalumab 6 avelumab 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06884683 2025-03-19

NivoMet

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡